INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $111,000 | -43.1% | 21,500 | -13.3% | 0.00% | -50.0% |
| Q4 2015 | $195,000 | -7.1% | 24,800 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $210,000 | -19.5% | 24,800 | +4.2% | 0.00% | 0.0% |
| Q2 2015 | $261,000 | -18.4% | 23,800 | +3.9% | 0.00% | -25.0% |
| Q1 2015 | $320,000 | -25.9% | 22,900 | -11.9% | 0.00% | -20.0% |
| Q4 2014 | $432,000 | +13.4% | 26,000 | -8.5% | 0.01% | 0.0% |
| Q3 2014 | $381,000 | +8.2% | 28,400 | +2.9% | 0.01% | 0.0% |
| Q2 2014 | $352,000 | +3.5% | 27,600 | -3.5% | 0.01% | 0.0% |
| Q1 2014 | $340,000 | -6.8% | 28,600 | +5.5% | 0.01% | -16.7% |
| Q4 2013 | $365,000 | -21.7% | 27,100 | +1.5% | 0.01% | -25.0% |
| Q3 2013 | $466,000 | +12.6% | 26,700 | +8.1% | 0.01% | 0.0% |
| Q2 2013 | $414,000 | – | 24,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |